Hui Feng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Hui Feng has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
Baorui Chu
Beijing Institute of Ophthalmology, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China
1 shared publicationChao Wu
Beijing Institute of Ophthalmology, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China
1 shared publicationFan Cao
Beijing Institute of Ophthalmology, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China
1 shared publication- Fengyang Lei
Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School
1 shared publication Ke Hu
The First Affiliated Hospital of Chongqing Medical University, Chongqing Key Laboratory of Ophthalmology, Chongqing Eye Institute, Chongqing Branch (Municipality Division) of National Clinical Research Center for Ocular Diseases, Chongqing, China
1 shared publication- Shang Li
Beijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University
1 shared publication
Latest Publications
- Open Access
- 2 January 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (1) , eaeb3991
Apolipoprotein E drives microglia activation in the development of autoimmune uveitis through up-regulation of peptidyl prolyl isomerase F
Autoimmune uveitis (AU) is a category of sight-threatening diseases with different pathological causes. Transcriptomic analysis of patients with AU revealed a highly oxidative stress profile as well as an up-regulated apolipoprotein E ( APOE ) expression in their peripheral blood mononuclear cells (PBMCs). In addition, single-cell RNA sequencing of retinal microglia also identified an up-regulated expression of APOE in a murine model of experimental AU (EAU). Our results and others previously suggested that microglia are tightly associated with the development of AU. Meanwhile, although APOE has been reported to play a myriad of functions ranging from lipid metabolism to neural regeneration, little is known about its detailed mechanism in the development of AU. In this study, a murine EAU model was used to investigate the association between APOE , microglia, and EAU, and it is found that APOE is indispensable for EAU induction as APOE −/− mice failed to develop EAU. In vitro studies using microglial cells further demonstrated that APOE is positively corelated with microglial inflammation, which could be reversed by knocking down APOE using short hairpin RNA. Proteomic analysis indicated that APOE -mediated microglial activation relies on reactive oxygen species (ROS) pathway, through peptidyl prolyl isomerase F ( PPIF ), which was further verified in PBMCs derived from patients with AU. Supplementation of PPIF reverses APOE deficiency–caused ROS activation in vitro. In addition, Adeno-associated virus-mediated overexpression of PPIF exacerbated EAU phenotype, suggesting its important role in driving uveitis initiation. These results provide an understanding of APOE and PPIF in the pathogenesis of uveitis.
- 2 January 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (1) , eaeb3991
Open AccessApolipoprotein E drives microglia activation in the development of autoimmune uveitis through up-regulation of peptidyl prolyl isomerase F
Autoimmune uveitis (AU) is a category of sight-threatening diseases with different pathological causes. Transcriptomic analysis of patients with AU revealed a highly oxidative stress profile as well as an up-regulated apolipoprotein E ( APOE ) expression in their peripheral blood mononuclear cells (PBMCs). In addition, single-cell RNA sequencing of retinal microglia also identified an up-regulated expression of APOE in a murine model of experimental AU (EAU). Our results and others previously suggested that microglia are tightly associated with the development of AU. Meanwhile, although APOE has been reported to play a myriad of functions ranging from lipid metabolism to neural regeneration, little is known about its detailed mechanism in the development of AU. In this study, a murine EAU model was used to investigate the association between APOE , microglia, and EAU, and it is found that APOE is indispensable for EAU induction as APOE −/− mice failed to develop EAU. In vitro studies using microglial cells further demonstrated that APOE is positively corelated with microglial inflammation, which could be reversed by knocking down APOE using short hairpin RNA. Proteomic analysis indicated that APOE -mediated microglial activation relies on reactive oxygen species (ROS) pathway, through peptidyl prolyl isomerase F ( PPIF ), which was further verified in PBMCs derived from patients with AU. Supplementation of PPIF reverses APOE deficiency–caused ROS activation in vitro. In addition, Adeno-associated virus-mediated overexpression of PPIF exacerbated EAU phenotype, suggesting its important role in driving uveitis initiation. These results provide an understanding of APOE and PPIF in the pathogenesis of uveitis.
- Open Access
- 1 January 2023
- Published by SAGE Publications in Clinical Medicine Insights: Case Reports
- Vol. 16
Leucocytoclastic Vasculitis Presenting as Bilateral Ulcerative Keratitis: A Case Report
Introduction: Small artery disease caused by neutrophils and immune-mediated is known as leucocytoclastic vasculitis (LCV). Clinically, it manifests as palpable, asymptomatic purpuric papules on the limbs. Ocular manifestation is rare. Here, we describe a case of peripheral ulcerative keratitis (PUK) associated with LCV. Case presentation: A 59-year-old man was referred to the hospital with blurred vision due to corneal perforation in his left eye. He complained of itchy nodules on his hands and lower legs for 15 years and the skin biopsy of the back of his hand revealed LCV 6 years ago, which suggested erythema elevatum diutinum. The patient was under treatment with anti-inflammatory and immunosuppressive drugs and physical features of LCV seen in him included erythema on his hands and legs. After receiving conjunctival flap covering surgery, the corneal perforation was resolved. Conjunctival flaps covered cornea that limited his vision to hand motion. Six months later, he was referred to our clinic again because of pain, redness, photophobia, and tearing in the right eye, presenting with PUK. Necrotic tissue was removed during surgery, which also included a conjunctival flap covering procedure. Following surgery, the symptoms were reduced, and the postoperative eye condition remained stable. Conclusion: To our knowledge, it is the first case of PUK secondary to LCV which was diagnosed 6 years ago. This case demonstrates that PUK associated with LCV can be successfully treated by surgical interventions.
- 1 January 2023
- Published by SAGE Publications in Clinical Medicine Insights: Case Reports
- Vol. 16
Open AccessLeucocytoclastic Vasculitis Presenting as Bilateral Ulcerative Keratitis: A Case Report
Introduction: Small artery disease caused by neutrophils and immune-mediated is known as leucocytoclastic vasculitis (LCV). Clinically, it manifests as palpable, asymptomatic purpuric papules on the limbs. Ocular manifestation is rare. Here, we describe a case of peripheral ulcerative keratitis (PUK) associated with LCV. Case presentation: A 59-year-old man was referred to the hospital with blurred vision due to corneal perforation in his left eye. He complained of itchy nodules on his hands and lower legs for 15 years and the skin biopsy of the back of his hand revealed LCV 6 years ago, which suggested erythema elevatum diutinum. The patient was under treatment with anti-inflammatory and immunosuppressive drugs and physical features of LCV seen in him included erythema on his hands and legs. After receiving conjunctival flap covering surgery, the corneal perforation was resolved. Conjunctival flaps covered cornea that limited his vision to hand motion. Six months later, he was referred to our clinic again because of pain, redness, photophobia, and tearing in the right eye, presenting with PUK. Necrotic tissue was removed during surgery, which also included a conjunctival flap covering procedure. Following surgery, the symptoms were reduced, and the postoperative eye condition remained stable. Conclusion: To our knowledge, it is the first case of PUK secondary to LCV which was diagnosed 6 years ago. This case demonstrates that PUK associated with LCV can be successfully treated by surgical interventions.